Health
FDA Greenlights Roivant's New Treatment for Rare Autoimmune Disease
By Editor • August 27, 2026 • 1 min read
The FDA has approved Roivant's Lisraya, a new daily pill for treating dermatomyositis, a rare autoimmune disease affecting up to 70,000 people in the U.S.
Read more